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Family and twin studies indicate that melanoma suscept-
ibility has a strong genetic component. Very rarely, mel-
a n o m ar u n si nf a m i l i e si nw h i c ht h e r ei sa ni n h e r i t e d
mutation in a single ‘high penetrance’ gene, but in the
general population melanoma susceptibility is thought
to be governed by variation in a series of ‘low pene-
trance’ genes. We sought to identify new melanoma risk
genes of both classes by conducting an Australian gen-
ome-wide association study (GWAS) of ~2200 mela-
noma cases and ~4300 matched controls (from the
AMFS and Q-MEGA studies), in parallel with whole-
genome sequencing of cases from densely affected mela-
noma families with follow up genotyping of interesting
variants in the GWAS sample and other highly case-
loaded melanoma families.
Genotyping of the GWAS sample was carried out
using Illumina Hap610K or OMNI 1M arrays. All 25
SNPs that reached genome-wide statistical significance
(i.e. p<5 x 10
-8) map to chromosomal regions/genes pre-
viously associated with melanoma (e.g. MC1R, ASIP,
OCA2, MTAP/CDKN2A and SLC45A2). However, two
other genomic regions had multiple adjacent SNPs with
low p values. These were the focus of a replication
study using melanoma GWAS data generated by groups
from the MD Anderson Cancer Center and the Interna-
tional Melanoma Genetics Consortium (GenoMEL).
Both independent GWAS data sets support the original
Australian findings and thus indicate that the PARP1
gene and another broad region on 1q (which includes
SETDB1, a recently identified melanoma oncogene) are
novel low penetrance melanoma risk loci.
The three known high penetrance melanoma suscept-
ibility genes (CDKN2A, CDK4 and ARF) account for less
than half of all ‘familial’ melanoma. We sought to iden-
tify other genes responsible for susceptibility in multi-
case melanoma families using a next-generation sequen-
cing approach. Families were chosen on the basis that
they did not have a mutation in CDKN2A, CDK4 or
ARF; and had at least 5 melanoma cases. Whole-genome
or exome sequencing was carried out on X cases from Y
families. No convincing evidence has yet been obtained
to support the identification of a new familial melanoma
gene, however, follow up genotyping of several novel
SNPs in the GWAS sample showed that a non-synon-
ymous variant in the MITF gene is associated with mel-
anoma in the general population. This type of integrated
approach should help accelerate the discovery of new
loci that play a role in the aetiology of melanoma.
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